Brainfogged,
I said I don't have any science to back up my feelings, but after extensive searching I've become uneasy with Modafinil for the following reasons.
First, the symptoms of SJS are benign in the beginning. They are: fever, sore throat, cough, and eye pain. This is worrisome because while I'm taking Modafinil, how will I ever know if I've picked up a cold, a flu bug, or am developing SJS? It's like I can't simply chalk up my cough or sore throat to anything run-of-the-mill without risking overlooking a potentially fatal condition. It's hard to live like that. Additionally, Modafinil is prone to giving users rashes anyway. Sometimes the rash is simply an allergic reaction that can be taken care of with some hydrocortisone cream but how will you ever know? Again, not taking a Modafinil rash seriously and dismissing it as an allergic reaction could end in devastation. Basically every minor symptom needs to be treated with the utmost seriousness.
Also, your claim that the only drug that induced SJS is Sparlon is challenged by the following FDA Safety Alerts.
The FDA apparently feels issuing an alert for PROVIGIL is warranted. Provigil (modafinil) Tablets
Audience: Neuropsychiatric specialists, other healthcare professionals, consumers
[Posted 10/24/2007] FDA and Cephalon notified healthcare professionals of updates to the WARNINGS section of the prescribing information for Provigil (modafinil). Provigil is indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder. The revised labeling updates safety information to include warnings regarding serious rash, including Stevens-Johnson Syndrome (SJS) and hypersensitivity reactions, and psychiatric symptoms. Rare cases of serious or life-threatening rash, including Toxic Epidermal Necrolysis, and Drug Rash with Eosinophilia and Systemic Symptoms have been reported in adults and children in worldwide postmarketing experience. Angioedema and multi-organ hypersensitivity reactions have also been reported in postmarketing experience.
Physicians should instruct their patients to immediately discontinue the use of Provigil and contact them if a rash or other hypersensitivity reaction occurs. Healthcare professionals and consumers should also be aware that Provigil is not approved for use in pediatric patients for any indication. In addition, psychiatric adverse experiences (including anxiety, mania, hallucinations, and suicidal ideation) have been reported in patients treated with Provigil. Caution should be exercised when Provigil is given to patients with a history of psychosis, depression, or mania.
Additional labeling revisions were made to the CLINICAL PHARMACOLOGY, PRECAUTIONS, and PATIENT PACKAGE INSERT sections. See revised labeling below.
[September 2007 - Dear Healthcare Professional Letter - Cephalon]
[August 2007 - Label - Cephalon]
Here is another Safety Alert issued by the FDA regarding Provigil/Modafinil in relation to SJS.
FDA has been monitoring cases of serious skin reactions, including erythema multiforme (EM), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), in its postmarketing reviews of adverse event reports associated with the use of modafinil. The product labeling for modafinil has been recently updated to include a bolded warning for serious rash, including SJS.1 Based on postmarketing data for modafinil, a recently approved drug with a similar chemical structure, armodafinil, includes a similar bolded warning in the product labeling.2 Healthcare professionals and patients should be watchful for skin reactions associated with the use of modafinil and armodafinil and report cases to FDA's MedWatch.
Modafinil (Provigil) is an oral wakefulness-promoting agent to treat patients with excessive sleepiness (ES) associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSAHS), and shift work sleep disorder (SWSD).1 Modafinil is a controlled substance (C-IV) and has been available in the United States since 1998. The safety and efficacy in children under the age of 16 has not been established.
From the date of initial marketing, December 1998, to January 30, 2007, FDA received six cases of severe cutaneous adverse reactions associated with modafinil, including erythema multiforme (EM), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug rash with eosinophilia and systemic symptoms (DRESS) involving adult and pediatric patients.
The 6 cases from the United States occurred in four females and two males aged 49, 42, 17, 27, 15, and 7 years old, respectively. The median time-to-onset of adverse dermatologic effects following initiation of modafinil therapy was 17.5 days, ranging from 5 days to 5 weeks (see Table). Patients presented with a rash to either body extremities (arms, hands, and legs) or to the whole body with some experiencing eruptions in the mouth (lips, tongue), eyes, or genitals. In addition, some patients developed skin pigment changes, pruritus, ulcers, burning of the skin, mild skin scaling, sloughing, and/or fever. Skin biopsies from four patients confirmed TEN, SJS/TEN, SJS/EM, and eosinophilia with unspecified findings consistent with a drug hypersensitivity syndrome.3,4
There were no deaths. Five of 6 patients required hospital admission for management, including one patient with TEN who was admitted to the surgical burn unit 20 days after starting modafinil at recommended doses to treat a sleep disorder. In this case, the rash affected 50% of the total body surface area (BSA), with 20 to 30% of the skin denuded. Although this patient had an extensive medication history, modafinil was the primary suspect drug because it was the last agent added to the patient's drug regimen. In addition, modafinil discontinuation upon hospital admission coincided with patient improvement, despite continuation of other concomitant medications, such as celecoxib and propranolol, which have labeled warnings for TEN.
In one case of SJS, although potentially confounded with Lamictal therapy (labeled warning for SJS), rechallenge with modafinil resulted in recurrence of the rash including oral mucosal involvement, which supported a causal association with modafinil use. Modafinil was subsequently discontinued. In the SJS/TEN case, a 42-year-old female received concomitant medications (including escitalopram, which has a labeled warning for TEN) since 2005 without incidence before adding modafinil for sleep disorder in 2006. The patient's extensive body rash (30% of the body surface area), skin biopsy, and clinical presentation all aided the dermatologist in diagnosing SJS with overlapping TEN.
One case of DRESS syndrome was reported in a 15-year-old who was started on modafinil for attention deficit hyperactivity disorder (ADHD), an unapproved indication. After 5 weeks of therapy, the patient developed a skin rash that progressed with multiple organ system involvement, including the cardiac, renal, respiratory, and pancreatic systems. Based on the clinical presentation, increased eosinophil count, and skin biopsy results, the consulting dermatologist diagnosed DRESS syndrome.
Although some cases were potentially confounded by drugs known to be associated with serious skin reactions, all cases had features that implicate modafinil. The cases described a temporal relationship with detailed clinical descriptions, relevant laboratory data, dermatologist-substantiated diagnoses, skin biopsy confirmation, positive dechallenges, and/or a positive rechallenge, all of which support an association between modafinil use and serious cutaneous skin reactions.
The above shows at least 6 people who developed serious and potentially fatal rashes from PROVIGIL/MODAFINL... not Sparlon. See the full Safety Newsletter here. I will include a few comments related to Provigil and SJS/TEN I found scouring the net.
PROVIGIL KILLS! I had "multi-organ" failures which NEARLY killed me after I started taking Provigil modafinil & a week after my dosage raised from 100 mg per day to 400 mg. What "failed" were my heart, my kidneys & my brain. My blood pressure sunk so low ( 80/45 ) that my brain & body got starved of oxygen. I was in cardiogenic shock, near death during a 9-day coma, spent 21 days in ICU, 32 days total in hospital. My heart, kidneys & brain were damaged permanently. DO NOT TAKE PROVIGIL!
Shane. : 2009-01-29 15:19:05
This drug can lead to very bad side effects, I should know. I have narcolepsy and started taking it. I felt great for 2 months and then it hit me. I got very, very depressed, stopped eating and started getting sores in my mouth, nose and on my lips. My tounge went numb and I couldn't eat right. All this after 2 months of being fine. If you do not have to take this then don't.... you are stupid!
Bruce Alan. : 2009-02-01 15:12:26
Shane, what you were experiencing was an apparently mild case of Stevens-Johnson Syndrome, on of at least a half dozen hypersensitivity syndromes which it somehow took the FDA 9 years to determine. SJS is a drug reaction so dangerous that severe cases can lead to death, even after hospitalized. Normally SJS is associated with skin rashes but it can cause mouth sores such as you describe as well as eye problems.
About 2 months after I began taking this dangerous medication I awoke one day in a state of complete delerium and ended up with (then) inexplicable acute kidney failure, heart failure and shock -- but no heart attack per se. This drug caused my whole body to become underperfused with blood due to lung failure. One eye heart and my mouth was sore too, but the MDs attributed that to a dental problem and didn't want to be bother. I survived only because I spent 9 days on a mechanical ventilator in a comatosw state before I regained consciousness. I spent 16 days in the ICU, 23 total in hospital and have been told that I overcame 1/250 odds in surviving. You should stop taking Provigil if you haven't already and NEVER, NEVER take Provigil again because your body has now been fully sensitized. Whoever the doctor was who told this writer it was a safe drug was reading from outdaated literature. I had my Provigil hell in January 2007. In the late part of 2007, the FDA for the first time released this information although they were aware of it in 2005. They required Cephalon, Provgil's maker, to include in BOLD print warnings about these hypersensitivity reactions. In 2006 the FDA refused to permit Provigil (under the alias 'Sparlon' to be marketed for use on ADHD ADD because the FDA committee thought that the occasion of just ONE case of Stevens-Johnson syndrome such as you had was deemed sufficient reason to deny approval.
Using Provigil for a legit purpose is bad enough; taking Provigil for 'fun' just might make it the last fun you will ever have. This drug has killed others and it CAN KILL YOU TOO. Dexedrine, Adderall and the other stimulants are far safer, both therapeutically and, if you must, for fun.
Provigil works wonderful for me with only one problem. On my second day taking 200mg of Provigil for narcolepsy I noticed a rash on my left hip and under my right arm and around to my back. The rash was not bad, just a slightly itchy red patch with small red bumps. I waited a month and tried again on the off chance that the original rash was caused by something else. On the first day of trying Provigil again the rashes returned in the exact same locations. My doctor is baffled, he is a Sleep Specialist with many patients on Provigil and has never seen this before. I am very frustrated because Provigil works wonders for me and I thought I might have finally found the answer to a problem that has plagued me for over 10 years now. Has anyone else experienced this?
I don't know if you are aware of the serious complications that can arise from the rash you are describing. I have been suffering from a similar terrible rash across my back which is now moving around my shoulders, up the back of my neck, and onto my arms.
I'm writing this to let you know that it's better to deal with the grind and the fog than live with the pain and anguish that are caused by SJS & TENS resulting from the use of Provigil. I know it's rough, but I'm dealing with the same predicament. It's sucks!
Here is some information that might be useful.
The Types of Rashes Provigil (modafinil) Causes
Rashes are not created equal. Some rashes are harmless blotches caused by anything from dry air to cheap soap. The rashes caused by provigil are specifically caused by the use of pharmaceuticals and thus are particularly nasty. They start small and are often initially misdiagnosed. They can expand across the body, become open sores, and invite foreign infections not related to the rash itself. The result can often be fatal for the sufferer.
Erythema multiforme (EM) bulbous - Typically round with well-defined borders. Shows up mostly on the hands, feet, arms, or legs. The rashes are small and irritating, but don’t usually cover the body.
Stevens-Johnson syndrome (SJS) blotchy – These are large oddly shaped blisters that cover the back, chest, or both. The lesions are small to large, irritating, and contain puss. Treatment should be immediate to avoid infections and further spreading.
Toxic epidermal necrolysis (TEN) with spots – These are widespread, irregularly shaped blisters. These blisters are huge and become filled with puss. They can cover the body and leave large open sores that are prone to a variety of infections.
Toxic epidermal necrolysis (TEN) without spots – Like it’s spotty brother, it is widespread, covering the chest and back. These rashes are smaller, but do not commonly blister. They peel off in large strips of skin exposing the area to infection.
Overlap Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) all above – This is the most deadly side effect of the drug, which culminates all of the worst elements of the above rashes. Symptoms are described above, but only manifests itself once the rash has become fully realized. Once these rashes are diagnosed, the patient is immediately hospitalized in the burn unit and treated as critical.
I hope you are doing well... and all the best to you!:o)
Here is a small discussion on Brainmeta.com about a user who tried Modafinil and felt like he started experiencing symptoms of SJS.
Also, SJS can be caused by infections like herpes simplex. As an HSV2 carrier myself, I feel this disposes me even more to the susceptibility of developing SJS perhaps exacerbating things by introducing a drug that is prone to causing it.
I could go on and on. My point is, developing a rash or symptoms indicative of a serious medical emergency don't seem to be as rare as the literature suggests.
Just have a look on askapatient.com here and search the pages for instances of the word "rash". It comes up quite a lot.
People have taken Modafinil for months before they started showing signs of anything serious. Look at this data from ehealthme.com
Do you still think my fears are unfounded or that I'm being paranoid? For me, it's hard to ignore this information.
This is a post-marketing study of Sjs (Erythema multiforme) among people who take Provigil. The study is created by eHealthMe based on 58 reports from FDA and user community. What is Provigil Provigil has active ingredients of modafinil. It is used in narcolepsy, fatigue, drowsiness, sleep disorder, chronic fatigue syndrome, sleep apnea. On Mar, 24, 2012: 6,757 people reported to have side effects when taking Provigil. Among them, 58 people (0.86%) have Sjs. Time on Provigil when people have Sjs * : < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years Sjs 90.28% 8.33% 0.00% 0.00% 1.39% 0.00% 0.00%
Gender of people who have Sjs when taking Provigil * : Female Male Sjs 65.00% 35.00%
Age of people who have Sjs when taking Provigil * : 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+ Sjs 0.00% 0.00% 12.36% 10.11% 5.62% 28.09% 31.46% 12.36%
Edited by semi-retarded-individual, 06 April 2012 - 09:52 PM.